Management of Long-Term Post-Viral Myalgia and Malaise
There is currently insufficient evidence to recommend any specific intervention for the management of long-term post-viral myalgia and malaise, though symptom-specific approaches may provide relief for some patients. 1
Understanding Post-Viral Myalgia and Malaise
- Post-viral myalgia and malaise often overlap with symptoms seen in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), particularly following COVID-19 infection 1
- These symptoms can significantly reduce quality of life and may persist for months or years after the initial infection 2
- Approximately 38% of patients hospitalized with COVID-19 experience musculoskeletal pain as a long-term post-COVID sequela 2
Recommended Approaches for Management
Pacing and Activity Management
- Pacing is recommended as a primary management strategy for patients with post-exertional malaise (PEM), which frequently accompanies post-viral myalgia and malaise 1, 3
- Exercise should be avoided in patients with PEM as it may worsen symptoms; studies show physical activity worsened symptoms in 75% of long COVID patients 1, 4
- Cognitive pacing should be considered alongside physical activity management for those experiencing cognitive dysfunction 1
Pharmacological Options
- Low-dose naltrexone has shown promise for neuroinflammation in ME/CFS and may help with post-viral myalgia 1
- H1 and H2 antihistamines (particularly famotidine) may alleviate symptoms in some patients but are not curative 1
- For pain management, consider:
Supplements with Limited Evidence
- Coenzyme Q10 and D-ribose have shown some promise in treating fatigue in ME/CFS and may be worth considering 1
- These supplements may deserve further study but currently have limited evidence 1
Special Considerations
For Postural Orthostatic Tachycardia Syndrome (POTS)
- If POTS is present alongside myalgia and malaise, consider:
For Immune Dysfunction
- Intravenous immunoglobulin may be considered for immune dysfunction but should be implemented in consultation with an immunologist 1
Emerging Treatments Under Investigation
- Anticoagulant regimens have shown promise in addressing abnormal clotting in long COVID 1
- BC007 (a drug that neutralizes G protein-coupled receptor autoantibody levels) is being investigated 1
- Paxlovid has shown potential in both prevention and treatment of long COVID symptoms in early studies 1
- Probiotics may help alleviate both gastrointestinal and non-gastrointestinal symptoms 1
Important Cautions
- Graded exercise therapy and cognitive behavioral therapy remain controversial for management of ME/CFS and should be further investigated before recommending for post-viral conditions 1
- Avoid recommending exercise for patients with PEM as it may significantly worsen their condition 1, 4
- Be aware that 50% of individuals with pre-existing musculoskeletal pain experienced worsening of their symptoms after COVID-19 2